Poly Medicure Limited (BOM:531768)
India · Delayed Price · Currency is INR 1,348.40
+19.80 (1.49%)
At close: May 29, 2026
Poly Medicure Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 3,221 | 3,386 | 2,583 | 1,793 | 1,465 |
Depreciation & Amortization | 1,155 | 823.57 | 628.68 | 562.17 | 530.31 |
Other Amortization | - | 13.72 | 16.62 | 13.94 | 14.52 |
Loss (Gain) From Sale of Assets | 2.21 | -1.2 | -6.23 | -1 | -5.31 |
Loss (Gain) on Equity Investments | -56.84 | -51.8 | -25.27 | -19.27 | -24.47 |
Stock-Based Compensation | 74.09 | 12.24 | 21.14 | 19.27 | 9.31 |
Provision & Write-off of Bad Debts | 36.24 | 35.08 | 23.09 | 7.36 | 6.91 |
Other Operating Activities | -479.33 | -269.8 | -173.24 | 32.57 | -127.67 |
Change in Accounts Receivable | -993.1 | -837.53 | -366.86 | -287.97 | -507.36 |
Change in Inventory | -371.88 | -645.42 | -123.76 | -402.91 | -418.82 |
Change in Accounts Payable | 122.24 | -72.79 | 37.62 | 37.69 | 247.02 |
Change in Other Net Operating Assets | -246.43 | 12.55 | 46.43 | 158.58 | 45.22 |
Operating Cash Flow | 2,464 | 2,404 | 2,661 | 1,911 | 1,235 |
Operating Cash Flow Growth | 2.48% | -9.64% | 39.27% | 54.73% | 3.99% |
Capital Expenditures | -3,084 | -3,310 | -2,770 | -2,393 | -1,556 |
Sale of Property, Plant & Equipment | 25.83 | 13.8 | 19.16 | 1.48 | 15.14 |
Cash Acquisitions | -4,192 | - | - | - | - |
Investment in Securities | 4,818 | -8,797 | 204.42 | 577.64 | 645.43 |
Other Investing Activities | 178.39 | 150.83 | 137.2 | 21.22 | 41.89 |
Investing Cash Flow | -2,254 | -11,943 | -2,409 | -1,792 | -853.32 |
Long-Term Debt Issued | 745.68 | 85.85 | 211.2 | 209.9 | - |
Long-Term Debt Repaid | -33.3 | -21.82 | -17.73 | -14.16 | -74.22 |
Net Debt Issued (Repaid) | 712.38 | 64.03 | 193.47 | 195.74 | -74.22 |
Issuance of Common Stock | 3.38 | 10,004 | 2.64 | 3.51 | 0.99 |
Common Dividends Paid | -354.31 | -303.41 | -287.4 | -239.73 | -239.16 |
Other Financing Activities | -159.93 | -259.08 | -110.24 | -84.58 | -41 |
Financing Cash Flow | 201.51 | 9,505 | -201.54 | -125.05 | -353.38 |
Foreign Exchange Rate Adjustments | 13.85 | - | - | - | - |
Miscellaneous Cash Flow Adjustments | - | - | - | -0 | 0 |
Net Cash Flow | 425.29 | -33.54 | 49.91 | -6.95 | 28.03 |
Free Cash Flow | -620.17 | -906.06 | -109.34 | -482.23 | -321.06 |
Free Cash Flow Margin | -3.31% | -5.43% | -0.80% | -4.32% | -3.48% |
Free Cash Flow Per Share | -6.11 | -9.13 | -1.14 | -5.02 | -3.35 |
Cash Interest Paid | 159.93 | 112.52 | 110.24 | 84.58 | 41 |
Cash Income Tax Paid | 1,017 | 924.12 | 743.01 | 578.67 | 474.56 |
Levered Free Cash Flow | -3,094 | -1,645 | -651.38 | -996.27 | -654.54 |
Unlevered Free Cash Flow | -2,979 | -1,578 | -589.07 | -960.31 | -635.93 |
Change in Working Capital | -1,489 | -1,543 | -406.57 | -494.6 | -633.94 |